Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,727 | 89 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $575.87 | 32 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $158.20 | 6 | $0 (2023) |
| GlaxoSmithKline, LLC. | $148.26 | 7 | $0 (2023) |
| PFIZER INC. | $102.65 | 6 | $0 (2023) |
| Novo Nordisk Inc | $94.97 | 5 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $89.55 | 4 | $0 (2023) |
| Mylan Specialty L.P. | $62.58 | 3 | $0 (2023) |
| Nestle HealthCare Nutrition Inc. | $62.25 | 3 | $0 (2022) |
| Exact Sciences Corporation | $53.22 | 2 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $53.21 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $71.60 | 3 | ABBVIE INC. ($31.67) |
| 2023 | $616.41 | 30 | ABBVIE INC. ($194.77) |
| 2022 | $631.23 | 33 | ABBVIE INC. ($212.81) |
| 2021 | $407.98 | 23 | AbbVie Inc. ($136.62) |
All Payment Transactions
89 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: PSYCHIATRY | ||||||
| 02/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $31.67 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2023 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Endogenous Testosterone Replacement Therapy | ||||||
| 10/16/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $31.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Gastroenterology | ||||||
| 10/05/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: RESPIRATORY | ||||||
| 09/29/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $31.01 | General |
| Category: Oncology | ||||||
| 09/25/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Obesity | ||||||
| 09/20/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: VACCINES | ||||||
| 08/15/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Cardiology | ||||||
| 08/06/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/24/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.82 | General |
| Category: PSYCHIATRY | ||||||
| 06/15/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/14/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Oncology | ||||||
| 04/19/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: VACCINES | ||||||
| 03/29/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: RESPIRATORY | ||||||
| 03/02/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 489 | 559 | $168,420 | $40,803 |
| 2022 | 10 | 482 | 552 | $161,277 | $43,033 |
| 2021 | 8 | 403 | 454 | $115,860 | $30,823 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 152 | 175 | $59,450 | $14,489 | 24.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 75 | 84 | $38,736 | $9,592 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 152 | 181 | $40,934 | $9,036 | 22.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 16 | $9,410 | $3,103 | 33.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $12,216 | $2,632 | 21.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 12 | $4,680 | $1,559 | 33.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 23 | 24 | $1,704 | $230.92 | 13.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 23 | 25 | $750.00 | $85.25 | 11.4% |
| 85610 | Blood test, clotting time | Office | 2023 | 12 | 18 | $540.00 | $75.60 | 14.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 143 | 163 | $54,442 | $12,963 | 23.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 45 | 50 | $27,450 | $9,899 | 36.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 54 | 66 | $29,568 | $7,800 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 126 | 144 | $32,256 | $7,674 | 23.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 32 | 34 | $8,670 | $2,173 | 25.1% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 15 | 15 | $5,850 | $2,038 | 34.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 16 | $1,136 | $151.30 | 13.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 13 | 15 | $435.00 | $144.11 | 33.1% |
| 85610 | Blood test, clotting time | Office | 2022 | 19 | 28 | $840.00 | $118.40 | 14.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 19 | 21 | $630.00 | $72.27 | 11.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 155 | 182 | $40,768 | $10,997 | 27.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 106 | 118 | $39,412 | $10,173 | 25.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 37 | 38 | $17,024 | $4,276 | 25.1% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 20 | 21 | $11,529 | $4,001 | 34.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 11 | 11 | $2,805 | $604.12 | 21.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 17 | $2,312 | $522.47 | 22.6% |
About Brendan Ryan, PA-C
Brendan Ryan, PA-C is a Physician Assistant healthcare provider based in Raynham, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2014. The National Provider Identifier (NPI) number assigned to this provider is 1396152187.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brendan Ryan, PA-C has received a total of $1,727 in payments from pharmaceutical and medical device companies, with $71.60 received in 2024. These payments were reported across 89 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($1,727).
As a Medicare-enrolled provider, Ryan has provided services to 1,374 Medicare beneficiaries, totaling 1,565 services with total Medicare billing of $114,659. Data is available for 3 years (2021–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Raynham, MA
- Active Since 07/14/2014
- Last Updated 06/24/2019
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1396152187
Products in Payments
- VRAYLAR (Drug) $385.11
- TRELEGY ELLIPTA (Drug) $128.11
- UBRELVY (Drug) $127.24
- XARELTO (Drug) $124.11
- STIOLTO RESPIMAT (Drug) $89.55
- PREVNAR 20 (Biological) $72.99
- ZENPEP (Drug) $62.25
- Ozempic (Drug) $56.80
- Cologuard Collection Kit (Device) $53.22
- REXULTI (Drug) $45.06
- YUPELRI (Drug) $38.72
- INVOKANA (Drug) $34.09
- NOCDURNA (Drug) $33.77
- NURTEC ODT (Drug) $33.45
- CREON (Drug) $31.85
- CAPLYTA (Drug) $31.83
- QULIPTA (Drug) $31.67
- Yupelri (Drug) $23.86
- ABILIFY MAINTENA (Drug) $23.39
- STRENSIQ (Biological) $23.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Raynham
Mr. Christopher Massey, Pa-C, PA-C
Physician Assistant — Payments: $185,771
Mrs. Lana Savini, Pa-C, PA-C
Physician Assistant — Payments: $460.33
Lauren Martinez, Pa, PA
Physician Assistant — Payments: $150.88
Alaina Annichiarico, Pa-C, PA-C
Physician Assistant — Payments: $63.04
Catherine Green
Physician Assistant — Payments: $36.22
Rebecca Amaral, Pa-C, PA-C
Physician Assistant